NCTC
CC icon

New Covenant Trust Company’s Chemours CC Stock Holding History

New Covenant Trust Company’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,096
Closed -$28.8K – 134
2024
Q1 		$28.8K Buy
+1,096
New +$31.2K 0.03% 213

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

New Covenant Trust Company's CC Position: Q2 2024 in Review

New Covenant Trust Company sold out of Chemours (CC) in Q2 2024, closing a stake of 1,096 shares — an estimated $28.8K sold.

New Covenant Trust Company first reported a position in CC in Q1 2024 and held it in 1 quarter. The position peaked at $28.8K in Q1 2024. 435 funds tracked by Wall St. Rank hold CC as of Q2 2024.

  • New Covenant Trust Company reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
  • New Covenant Trust Company sold 1,096 Chemours shares in Q2 2024, an estimated $28.8K.
  • New Covenant Trust Company first reported a position in Chemours in Q1 2024 and held it in 1 quarter.
  • New Covenant Trust Company's Chemours position peaked at $28.8K in Q1 2024.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on New Covenant Trust Company's 13F filing for Q2 2024, filed 30 Jul 2024.